Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 12 - per page Next page
Order by
Each Dose of Neo-Penotran® contains a combination of Metronidazole and Miconazole Nitrate in therapeutic concentrations for the local treatment of the treatment three main types of vaginal infections and mixed forms of vaginitis. More
pH maintenance, Spermicide, Microbicide Lubricant More
A liquid system which enables rapid transmigration of therapeutic doses of up to large molecules More
Collagen-based biodegradable matrices for localized drug delivery More
Sinlice is a new anti-lice composition specifically formulated as a dry-on, suffocation-based product. It has been designed to adhere to hair shafts and keratins. More
Novel Dual Chamber Dispenser with polycarbonate and stainless steel components for accurate Rx dosing. More
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
A new veterinary medicinal composition designed to maintain the oxygenic consumption, to restore hydric, electrolytic and energetic status, as well as the blood pH in affected mammals. More
Novel use of amine-borane compounds for the treatment of medical conditions associated with microorganisms.These compounds are an answer to the big search for antimicrobial agents to combat the development of resistance to current medications More
Treatment of Skin and Epithelial Tumors Using Intralesional Injection of Combined Antigens More
Displaying 1..10 of 12 - per page Next page
Order by

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Infectious diseases del
Development phase
Phase I del

Browse By

Research Partnership for Due Diligence Execution
Biobusiness 2009
Pharmaceutical Antitrust
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us